Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 223-231 , October 2010

Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy

  • Ali Sak, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Ali Sak, PhD, Department of Radiotherapy, University Hospital Essen, 45122 Essen, Germany
    • ,
  • Martin Stuschke, MD

References 

  1. Sak A, Grehl S, Erichsen P. Gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: Dependence on the dose-distribution, irradiated site and time from start of treatment. Int J Radiat Biol. 2007;83:639–652
  2. Rothkamm K, Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003;100:5057–5062
  3. Frankenberg-Schwager M. Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionising radiation. Radiother Oncol. 1989;14:307–320
  4. Rogakou EP, Pilch DR, Orr AH. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858–5868
  5. Paull TT, Rogakou EP, Yamazaki V. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10:886–895
  6. Bassing CH, Chua KF, Sekiguchi J. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci U S A. 2002;99:8173–8178
  7. Böcker W, Iliakis G. Computational methods for analysis of foci: Validation for radiation-induced gamma-H2AX foci in human cells. Radiat Res. 2006;165:113–124
  8. Harper JV, Reynolds P, Leatherbarrow EL. Induction of persistent double strand breaks following multiphoton irradiation of cycling and G1-arrested mammalian cells-replication-induced double strand breaks. Photochem Photobiol. 2008;84:1506–1514
  9. Leatherbarrow EL, Harper JV, Cucinotta FA. Induction and quantification of gamma-H2AX foci following low and high LET-irradiation. Int J Radiat Biol. 2006;82:111–118
  10. Karagiannis TC, Harikrishnan KN, El-Osta A. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. Oncogene. 2007;26:3963–3971
  11. Goodarzi AA, Noon AT, Deckbar D. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell. 2008;31:167–177
  12. Rothstein R, Michel B, Gangloff S. Replication fork pausing and recombination or “gimme a break”. Genes Dev. 2000;14:1–10
  13. Krüger I, Rothkamm K, Löbrich M. Enhanced fidelity for rejoining radiation-induced DNA double strand breaks in the G2 phase of Chinese hamster ovary cells. Nucleic Acids Res. 2004;32:2677–2684
  14. Takata M, Sasaki MS, Sonoda E. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 1998;17:5497–5508
  15. Tanaka T, Huang X, Halicka HD. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A. 2007;71A:648–661
  16. Aten JA, Stap J, Krawczyk PM. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science. 2004;303:92–95
  17. Andrievski A, Wilkins RC. The response of gamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures. Int J Radiat Biol. 2009;85:369–376
  18. Scherthan H, Hieber L, Braselmann H. Accumulation of DSBs in gamma-H2AX domains fuel chromosomal aberrations. Biochem Biophys Res Commun. 2008;371:694–697
  19. Hamasaki K, Imai K, Nakachi K. Short-term culture and gammaH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ Mol Mutagen. 2007;48:38–47
  20. Porcedda P, Turinetto V, Lantelme E. Impaired elimination of DNA double-strand break-containing lymphocytes in ataxia telangiectasia and Nijmegen breakage syndrome. DNA Repair (Amst). 2006;5:904–913
  21. Kato TA, Wilson PF, Nagasawa H. A defect in DNA double strand break processing in cells from unaffected parents of retinoblastoma patients and other apparently normal humans. DNA Repair (Amst). 2007;6:818–829
  22. Sedelnikova OA, Bonner WM. GammaH2AX in cancer cells: A potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle. 2006;5:2909–2913
  23. Bartkova J, Horejsi Z, Koed K. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–870
  24. Baňuelos CA, Banáth JP, Kim JY. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation. Clin Cancer Res. 2009;15:3344–3353
  25. Leenders KL, Perani D, Lammertsma AA. Cerebral blood flow, blood volume and oxygen utilization (Normal values and effect of age). Brain. 1990;113:27–34
  26. Rothkamm K, Balroop S, Shekdar J. Leukocyte DNA damage after multi-detector row CT: A quantitative biomarker of low-level radiation exposure. Radiology. 2007;242:244–251
  27. Qvarnström OF, Simonsson M, Johansson KA. DNA double strand break quantification in skin biopsies. Radiother Oncol. 2004;72:311–317
  28. Taneja N, Davis M, Choy JS. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem. 2004;279:2273–22780
  29. Geisel D, Heverhagen JT, Kalinowski M. DNA double-strand breaks after percutaneous transluminal angioplasty. Radiology. 2008;248:852–859
  30. Cramers P, Atanasova P, Vrolijk H. Pre-exposure to low doses: Modulation of X-ray-induced DNA damage and repair?. Radiat Res. 2005;64:383–390
  31. Sak A, Grehl S, Engelhard M. Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation. Clin Cancer Res. 2009;15:2927–2934
  32. Haaf T, Golub EI, Reddy G. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci U S A. 1995;92:2298–22302
  33. Fong PC, Boss DS, Yap TA. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123–134
  34. Murakawa Y, Sonoda E, Barber LJ. Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells. Cancer Res. 2007;67:8536–8543
  35. Iwasa T, Okamoto I, Suzuki M. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines. Clin Cancer Res. 2008;14:6496–6504
  36. Morrison C, Vagnarelli P, Sonoda E. Sister chromatid cohesion and genome stability in vertebrate cells. Biochem Soc Trans. 2003;31:263–265
  37. Pryor DI, Porceddu SV, Burmeister BH. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol. 2009;90:172–176
  38. Li L, Wang H, Yang ES. Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells. Cancer Res. 2008;68:9141–9146
  39. Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 2009;27:5459–5468
  40. Hickson I, Zhao Y, Richardson CJ. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004;64:9152–9159
  41. Veuger SJ, Curtin NJ, Richardson CJ. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res. 2003;63:6008–6015
  42. Kataoka Y, Murley JS, Baker KL. Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs. Radiat Res. 2007;168:106–114
  43. Mahmoudi M, Gorenne I, Mercer J. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res. 2008;103:717–725
  44. Flynn RT, Barbee DL, Mackie TR, et al. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: A phantom study. Phys. Med Biol. 2007;52:6073–6091

PII: S1053-4296(10)00038-X

doi: 10.1016/j.semradonc.2010.05.004

Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 223-231 , October 2010

Article Tools

* Image Usage & Resolution